Has Inghams (ASX:ING) Got a Legitimate Turnaround Plan? The Market Seems To Think So For The First Time In a While

Inghams (ASX:ING) investors would be thankful yesterday’s Investor Day didn’t lead to a further decline, as CSL’s own ill-fated event did – capping off a $100bn market cap decline. But Inghams shares finished the day slightly higher than they started. There’s a long way to go, but investors got clear signs that stabilisation is occurring in the numbers. The company has argued for several years that its challenges were operational rather than structural. Today’s material finally provides evidence that this claim is credible.

The market will focus on the reaffirmed FY26 Underlying EBITDA (pre‑AASB 16) guidance of $180–200m. The more interesting story sits beneath that range. Inghams has quantified more than $130m of embedded EBITDA uplift already sitting inside the existing asset base. That is the first time the company has provided a structured, evidence‑based roadmap for earnings recovery.

Inghams (ASX:ING) is a business that is finally stabilising

The first six months of the new operating model have delivered measurable improvements. Investors have heard “stabilisation” rhetoric before, but the difference this time is the presence of hard data. The most important early indicator is yield. FY26 chicken processing yield has improved from 60.8% to roughly 63.2%. A 240‑basis‑point uplift is not incremental; it is transformational. Yield is the single most powerful lever in poultry economics, and this improvement alone equates to around $20m of annualised EBITDA. It also validates the new execution model built around balance, process control and site discipline.

A second indicator is the reduction in frozen inventory. Inghams has removed approximately $25m of excess frozen stock from the system. This matters because frozen inventory has been a multi‑year drag on working capital, mix and margins. Reducing it restores system balance, improves cash conversion and signals that planning discipline is taking hold.

A third indicator is the weekly EBITDA run‑rate. While the company does not disclose the exact number, the chart presented today shows a clear upward trajectory through FY26. The exit run‑rate appears comfortably above the FY25 average, reinforcing that stabilisation is not theoretical.

A fourth indicator is customer sentiment. Inghams has moved from twentieth to ninth in the Advantage Group survey and is now the number‑one preferred poultry supplier. That shift reflects improved reliability, service and planning. It also matters because customer trust is the gating factor for mix improvement and premiumisation.

Finally, the company has delivered or initiated $17.4m of annualised savings across transport, labour management, waste, packaging and planning. These are not aspirational savings; they are already in execution. Altogether, these datapoints confirm that stabilisation is real and measurable.

A larger pool of embedded EBITDA than the market appreciates

The most important slide in the entire deck was the one that quantifies more than $130m of EBITDA embedded in operational improvement. This is not a blue‑sky number. It is broken into specific components that are already underway.

First, High Performance Operations contributes around $100m. This includes yield, labour, planning and by‑product recovery. The company has been clear that earnings are suppressed by inconsistent execution across sites. Standardising site performance, fixing underperforming assets and extracting full value from automation investments are all levers that sit entirely within management’s control.

Second, integrated planning contributes more than $30m. The company has moved from fragmented planning to an end‑to‑end model that reduces cost‑to‑serve, improves flow and lowers working capital. The reduction in frozen inventory is the first visible proof point.

Third, customer mix, premium formats and pricing discipline contribute around $30m over five years. Inghams has segmented its customer base by value creation potential, aligned innovation to consumer demand and embedded commercial guardrails. The early signs are encouraging. Shifting low‑value material into higher‑value channels has already delivered a $3m net sales value benefit.

Fourth, the Advanced Ingredients Facility contributes around $5m of incremental EBITDA on an $8.5m investment. Ingredients harvesting is up 15% year‑to‑date, and strategic partnerships with pet food manufacturers are already in place. This is a structurally higher‑margin earnings pool that has historically been under‑monetised.
Even allowing for overlap and execution risk, the scale of the opportunity is undeniable. The company is effectively saying that the current asset base can support EBITDA of more than $300m without requiring major capital expansion.

New Zealand is emerging as a structural advantage

Ingham’s New Zealand business has often been overlooked, but today’s material shows it is becoming a genuine earnings engine even with the state of the economy. The market structure is rational, with four players and limited overcapacity. Inghams is one of only two vertically integrated processors with breeder farms and a hatchery. Half the population lives within three hours of the company’s hub in Waitoa, creating a logistics and service advantage.

The financial trajectory is compelling. New Zealand EBITDA (pre‑royalty) has grown from $34.1m in FY22 to $73.0m in FY25. Premium brands are accelerating growth: Waitoa is up 8.6%, Bostock Brothers is up 15.1%. Automation at Te Aroha is delivering a step‑change in performance, with yield improvements of 1–3%, labour productivity gains and $3–4m of run‑rate cost reduction. All major investments are generating ROIC above 20%.

The company now has a clear pathway to NZ$100m of EBITDA by 2030. New Zealand is becoming a structural cost‑advantaged platform that also serves as a test‑and‑learn market for innovation before scaling into Australia.
Ingredients and by‑products becoming a real earnings pool

One of the most under‑appreciated parts of the story is the ingredients platform. Ingredients harvesting is up 15% year‑to‑date, and the Advanced Ingredients Facility is already delivering $5m of incremental EBITDA. The company has demonstrated the ability to convert frames and other by‑products into higher‑value applications such as broth, functional proteins and pet food inputs. This is a structurally higher‑margin earnings pool that expands value per bird without requiring additional volume.

Inghams’ Capital discipline is finally becoming credible

For years, Inghams’ capital program has been criticised for failing to translate into returns. Today’s framework is the clearest articulation yet of capital discipline. The company has established ROIC thresholds for each category of investment.

Stay‑in‑business capex must exceed the cost of capital. Optimisation projects must exceed the cost of capital. Growth projects must exceed 20% ROIC. Leverage is targeted at 1.0–2.0 times pre‑AASB 16. Net debt is expected to fall from $475m in FY25 to $380–415m by FY28. Capex is held to around $80m in FY26. The message is simple: optimise first, grow second.

Investors liked the trading update as it confirmed FY26 is on track

Ingham’s trading update is broadly neutral but reassuring. Volumes are up 1.1%, and net sales price is up 1.1%. Feed costs are fully covered for FY26 but will be higher in FY27. Diesel adds a $7–10m headwind, partially offset. Packaging inflation is emerging. The company expects $60–80m of annualised savings to offset operating cost growth. FY26 EBITDA guidance of $180–200m is reaffirmed. The important point is that operational improvements are absorbing geopolitical cost pressures.

The company’s consensus bottom line shows a recovery with $59.4m in FY26, $81.6m in FY27, $96.5m in FY28, $115m in FY29 and $122.5m in FY30. Only in the latter does it surpass the company’s peak profit in its listed life which was $114m way back in 2018 – it had plunged to $35m during the COVID years. In one sense, light at the end of the tunnel, but still a long road.

Nonetheless, from our perspective, consensus does not appear to incorporate the full $130m of embedded EBITDA. If even half of that materialises, consensus will prove conservative.

Is Inghams on track?

In our view, yes. The company is finally delivering evidence that the operational reset is real. Stabilisation is working, optimisation is underway and growth is now grounded in credible, data‑backed initiatives. The next catalyst will be whether the FY26 exit run‑rate implies FY27 EBITDA materially above consensus. Based on the yield gains, inventory normalisation and early savings already banked, the probability is rising.